ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm An...(one to error in some disposable devices....),Health

Date:10/8/2009

one to error in some disposable devices. Secondly, it eliminates the subjective interpretation inherent in many product's visually read results. Additionally, Abaxis has accomplished significantly reducing the costs associated with routine Wellness Testing performed at the point-of-care, which will increase pet owner acceptance and positively impact animal health in the United States and worldwide".

The company's VetScan VS2 instrument, about the size of a shoebox, now performs in clinic and in minutes, 25 different tests configured in 9 panels. Almost one in four veterinary practices in North America incorporate Abaxis instruments into routine wellness testing and annual check-ups, as an aide in the diagnosis of sick pets, and in emergency medicine and critical care.

About Abaxis, Inc.

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs or rotors, which contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a Coagulation instrument to screen for and detect clotting disorders, a handheld instrument for the rapid assessment of certain critical care tests and a rapid point-of-care test for Heartworm infections in dogs.

This press release includes, s
'/>"/>

SOURCE Abaxis, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Curemark Announces Senior Executive Promotions
3. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
4. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
5. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
6. NuVasive Announces Conference Call and Webcast of Third Quarter 2009 Results
7. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
8. BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
9. BD Announces FDA 510(k) Clearance of BD Vacutainer(R) Rapid Serum Blood Collection Tube
10. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
11. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350